Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study (Q35677262)
Jump to navigation
Jump to search
scientific article published on 7 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study |
scientific article published on 7 December 2011 |
Statements
1 reference
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study (English)
1 reference
1 reference
W Timothy Garvey
1 reference
Michelle Look
1 reference
Kishore M Gadde
1 reference
Craig A Peterson
1 reference
Michael Schwiers
1 reference
Wesley W Day
1 reference
Charles H Bowden
1 reference
7 December 2011
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference